Compare STRL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | MEDP |
|---|---|---|
| Founded | 1955 | 1992 |
| Country | United States | United States |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 17.2B |
| IPO Year | 1996 | 2016 |
| Metric | STRL | MEDP |
|---|---|---|
| Price | $526.34 | $622.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 14 |
| Target Price | ★ $845.43 | $589.92 |
| AVG Volume (30 Days) | ★ 459.9K | 205.4K |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.42 | ★ 20.98 |
| EPS | 8.09 | ★ 8.53 |
| Revenue | ★ $957,958,000.00 | N/A |
| Revenue This Year | $64.87 | $12.72 |
| Revenue Next Year | $19.86 | $6.34 |
| P/E Ratio | ★ $62.44 | $70.11 |
| Revenue Growth | ★ 38.81 | N/A |
| 52 Week Low | $281.58 | $373.00 |
| 52 Week High | $1,005.68 | $677.90 |
| Indicator | STRL | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 56.46 |
| Support Level | $492.71 | $568.43 |
| Resistance Level | $531.00 | $632.08 |
| Average True Range (ATR) | 22.10 | 16.65 |
| MACD | 4.97 | -0.98 |
| Stochastic Oscillator | 85.00 | 66.29 |
Sterling Infrastructure Inc operates through subsidiaries within three segments: E-Infrastructure, Transportation, and Building Solutions in the United States, mainly across the Southern, Northeastern, Mid-Atlantic, and Rocky Mountain regions and the Pacific Islands. E-Infrastructure Solutions generates maximum revenue and provides site development and mission-critical electrical services for data centers, manufacturing, distribution centers, warehousing, and power generation. Transportation Solutions includes infrastructure and rehabilitation projects for highways, airports, ports, rail, and storm drainage systems. Building Solutions includes residential and commercial concrete foundations, parking structures, plumbing services, and surveys for new single-family residential builds.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.